US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Artiva Biotherapeutics, Inc.

6.79

-0.3300-4.63%

Pre-market: 7.120.3254+4.79%08:37 EDT

Volume:444.34K

Turnover:3.08M

Market Cap:331.93M

PE:-2.12

High:7.15

Open:7.11

Low:6.77

Close:7.12

52wk High:14.53

52wk Low:2.71

Shares:48.89M

Float Shares:18.98M

Volume Ratio:0.97

T/O Rate:2.34%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-3.2084

EPS(LYR):-3.4309

ROE:-36.58%

ROA:-22.34%

PB:0.96

PE(LYR):-1.98

Loading ...

Overview Company News Filings

Artiva Biotherapeutics Price Target Maintained with a $40.00/Share by Cantor Fitzgerald

Analysts Offer Insights on Healthcare Companies: Boston Scientific (BSX) and Artiva Biotherapeutics, Inc. (ARTV)

Artiva Biosciences: Buy Rating Reiterated on Strong AlloNK Sjögren’s Data and Favorable Safety, Price Target Maintained at $35

Artiva Highlights Phase 2a AlloNK Plus Rituximab Data in Sjögren Disease Showing Six-Month Symptom Improvement

Artiva Biotherapeutics to Present Updated AB-101 AlloNK Plus Rituximab Sjögren Disease Data at ISSjD 2026

Artiva Biotherapeutics Announces Oral Presentation of Allonk® Clinical Data at the 17TH International Symposium on SjÖGren’s Disease

THOMSON REUTERS

H.C. Wainwright Sticks to Their Buy Rating for Artiva Biotherapeutics, Inc. (ARTV)

Artiva Biotherapeutics Joins Stifel Virtual Immunology and Inflammation Forum Fireside Chat

Artiva Biotherapeutics Expands Equity Plan, Elects Directors

Artiva Biotherapeutics Shareholders Vote to Expand 2024 Equity Incentive Plan Share Pool by 5,097,095 Shares

Artiva Biotherapeutics CEO Fred Aslan Disposes of 23,429 Common Shares Worth $255,725

Artiva Biotherapeutics Launches Phase 3 Trial of AlloNK Plus Rituximab in Refractory Rheumatoid Arthritis

Artiva Biotherapeutics Provides Update on Planned Allonk® Data Disclosures and Development Milestones for the Remainder of 2026

THOMSON REUTERS

Artiva Biotherapeutics - to Disclose Updated Phase 2a Ra Data from at Least 20 Patients in H2 2026

THOMSON REUTERS

Artiva Biotherapeutics - Expects Phase 3 Ra Trial Topline Results by End of 2028

THOMSON REUTERS

Artiva Biotherapeutics Provides Update on Planned AlloNK® Data Disclosures and Development Milestones for the Remainder of 2026

Top Artiva Biotherapeutics Executives Quietly Unload a Wave of Shares

Artiva Biotherapeutics to Participate in Upcoming Investor Conferences in September

Artiva Biotherapeutics CMO Subhashis Banerjee Disposes of 8,222 Shares for $98,730.32

Artiva Biotherapeutics CMO Subhashis Banerjee Disposes of 429 Common Shares Worth $5,148 Under 10b5-1 Plan

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg1.tigeractivity.com/stock/ARTV/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ARTV","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ARTV\",,,,,undefined,":{"symbol":"ARTV","market":"US","secType":"STK","nameCN":"Artiva Biotherapeutics, Inc.","latestPrice":6.79,"timestamp":1790884800000,"preClose":7.12,"halted":0,"volume":444342,"hourTrading":{"tag":"盘前","latestPrice":7.1154,"preClose":6.79,"latestTime":"08:37 EDT","volume":603,"amount":4202.4374289,"timestamp":1790944649848,"change":0.3254,"changeRate":0.047923,"amplitude":0.070486},"delay":0,"changeRate":-0.04634831460674158,"floatShares":18984416,"shares":48885777,"eps":-3.20842,"marketStatus":"Pre-Mkt","change":-0.33,"latestTime":"10-02 08:37:46 EDT","open":7.11,"high":7.15,"low":6.77,"amount":3082693.5864174003,"amplitude":0.053371,"askPrice":7.75,"askSize":100,"bidPrice":6.8,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-3.20842,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1790947800000},"marketStatusCode":1,"adr":0,"listingDate":1721361600000,"exchange":"NASDAQ","adjPreClose":6.79,"preHourTrading":{"tag":"盘前","latestPrice":7.1154,"preClose":6.79,"latestTime":"08:37 EDT","volume":603,"amount":4202.4374289,"timestamp":1790944649848,"change":0.3254,"changeRate":0.047923,"amplitude":0.070486},"postHourTrading":{"tag":"盘后","latestPrice":6.75,"preClose":6.79,"latestTime":"19:30 EDT","volume":11823,"amount":80255.7885,"timestamp":1790897449524,"change":-0.04,"changeRate":-0.005891,"amplitude":0.007364},"volumeRatio":0.969849825374772,"impliedVol":2.0547,"impliedVolPercentile":0.9216},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ARTV\",,,,,undefined,":{"symbol":"ARTV","floatShares":18984416,"roa":"-22.34%","roe":"-36.58%","lyrEps":-3.430895,"volumeRatio":0.969849825374772,"shares":48885777,"dividePrice":0,"high":7.15,"amplitude":0.053371,"preClose":7.12,"low":6.77,"week52Low":2.71,"pbRate":"0.96","week52High":14.53,"institutionHeld":0,"latestPrice":6.79,"eps":-3.20842,"divideRate":0,"volume":444342,"delay":0,"ttmEps":-3.20842,"open":7.11,"prevYearClose":4.29,"prevWeekClose":6.99,"prevMonthClose":7.12,"prevQuarterClose":7.12,"fiveDayClose":7.49,"twentyDayClose":11.31,"sixtyDayClose":9.31},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ARTV\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-06","symbol":"ARTV","fiscalQuarterEnding":"2026/06","expectedEps":-0.64,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1785988800000,"reportTimeType":"post","actualEps":-0.63},{"market":"US","date":"2026-05-08","symbol":"ARTV","fiscalQuarterEnding":"2026/03","expectedEps":-0.88,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1778212800000,"reportTimeType":"pre","actualEps":-0.95},{"market":"US","date":"2026-03-10","symbol":"ARTV","fiscalQuarterEnding":"2025/12","expectedEps":-0.87,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1773115200000,"reportTimeType":"post","actualEps":-0.84},{"market":"US","date":"2025-11-12","symbol":"ARTV","fiscalQuarterEnding":"2025/09","expectedEps":-0.92,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1762923600000,"reportTimeType":"pre","actualEps":-0.88},{"market":"US","date":"2025-08-06","symbol":"ARTV","fiscalQuarterEnding":"2025/06","expectedEps":-0.84,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1754452800000,"reportTimeType":"post","actualEps":-0.87}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ARTV\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ARTV\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.6667,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":6,"updateTime":1735617600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ARTV\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ARTV","date":"2026-09-30","current":-2.116306,"percent":0.374768,"low":-11.820615,"twenty":-5.53795,"median":-1.821368,"eighty":-0.952359,"high":-0.499349,"avg":-3.338116,"sd":2.941745,"marketCap":343697550},"quantilePoints":[{"date":"2024-08-02","current":-10.391793,"twenty":-10.391793,"median":-10.391793,"eighty":-10.391793,"marketCap":269833291},{"date":"2024-08-09","current":-9.862789,"twenty":-10.391793,"median":-10.042112,"eighty":-9.943484,"marketCap":256097171},{"date":"2024-08-16","current":-10.185571,"twenty":-10.248334,"median":-10.131774,"eighty":-9.95245,"marketCap":264478532},{"date":"2024-08-23","current":-8.939273,"twenty":-10.248334,"median":-10.051078,"eighty":-9.342751,"marketCap":232117163},{"date":"2024-08-30","current":-8.088598,"twenty":-10.185571,"median":-9.943484,"eighty":-9.046867,"marketCap":263081639},{"date":"2024-09-06","current":-8.893463,"twenty":-10.142533,"median":-9.800025,"eighty":-8.930111,"marketCap":289259885},{"date":"2024-09-13","current":-8.019798,"twenty":-10.131774,"median":-9.459311,"eighty":-8.763533,"marketCap":260843926},{"date":"2024-09-20","current":-8.759053,"twenty":-10.07439,"median":-9.028935,"eighty":-8.450238,"marketCap":284888199},{"date":"2024-09-27","current":-9.946342,"twenty":-10.07439,"median":-9.323455,"eighty":-8.581333,"marketCap":323504758},{"date":"2024-10-04","current":-11.499524,"twenty":-10.277026,"median":-9.57298,"eighty":-8.727691,"marketCap":374022017},{"date":"2024-10-11","current":-10.566121,"twenty":-10.505561,"median":-9.728296,"eighty":-8.794895,"marketCap":343663087},{"date":"2024-10-18","current":-9.543111,"twenty":-10.587029,"median":-9.800025,"eighty":-8.869568,"marketCap":310389700},{"date":"2024-10-25","current":-7.586699,"twenty":-10.505561,"median":-9.574426,"eighty":-8.581333,"marketCap":246757383},{"date":"2024-10-31","current":-7.579232,"twenty":-10.485041,"median":-9.464706,"eighty":-8.226879,"marketCap":246514511},{"date":"2024-11-08","current":-10.424244,"twenty":-10.485041,"median":-9.3863,"eighty":-8.226879,"marketCap":339048530},{"date":"2024-11-15","current":-4.166082,"twenty":-10.46953,"median":-9.378833,"eighty":-8.149728,"marketCap":255280837},{"date":"2024-11-22","current":-4.310765,"twenty":-10.439178,"median":-9.30416,"eighty":-7.969021,"marketCap":264146442},{"date":"2024-11-29","current":-5.065892,"twenty":-10.411264,"median":-9.046867,"eighty":-7.81669,"marketCap":310417611},{"date":"2024-12-06","current":-4.598149,"twenty":-10.334409,"median":-8.970887,"eighty":-7.365669,"marketCap":281756204},{"date":"2024-12-13","current":-4.233469,"twenty":-10.223229,"median":-8.939273,"eighty":-5.058757,"marketCap":259410023},{"date":"2024-12-20","current":-3.963922,"twenty":-10.173512,"median":-8.885996,"eighty":-4.852633,"marketCap":242893280},{"date":"2024-12-27","current":-4.17401,"twenty":-10.150694,"median":-8.781454,"eighty":-4.667914,"marketCap":255766623},{"date":"2025-01-03","current":-3.95203,"twenty":-10.131774,"median":-8.549971,"eighty":-4.598149,"marketCap":242164600},{"date":"2025-01-10","current":-4.066984,"twenty":-10.131774,"median":-8.396892,"eighty":-4.398368,"marketCap":249208505},{"date":"2025-01-17","current":-2.687539,"twenty":-10.07439,"median":-8.17661,"eighty":-4.337719,"marketCap":164681643},{"date":"2025-01-24","current":-2.477451,"twenty":-10.049285,"median":-8.109405,"eighty":-4.224748,"marketCap":151808300},{"date":"2025-01-31","current":-2.140518,"twenty":-10.011532,"median":-8.012331,"eighty":-4.193829,"marketCap":131162371},{"date":"2025-02-07","current":-1.823404,"twenty":-9.967928,"median":-7.881014,"eighty":-4.108209,"marketCap":111730908},{"date":"2025-02-14","current":-1.589533,"twenty":-9.948785,"median":-7.698708,"eighty":-3.978192,"marketCap":97400205},{"date":"2025-02-21","current":-1.502326,"twenty":-9.945199,"median":-7.508293,"eighty":-3.804572,"marketCap":92056553},{"date":"2025-02-28","current":-1.478543,"twenty":-9.911206,"median":-5.18038,"eighty":-2.77871,"marketCap":90599193},{"date":"2025-03-07","current":-2.0216,"twenty":-9.837683,"median":-5.059946,"eighty":-2.521847,"marketCap":123875572},{"date":"2025-03-14","current":-2.219796,"twenty":-9.795827,"median":-4.998506,"eighty":-2.343471,"marketCap":136020236},{"date":"2025-03-21","current":-1.601424,"twenty":-9.736345,"median":-4.76067,"eighty":-2.165887,"marketCap":98128885},{"date":"2025-03-28","current":-1.319282,"twenty":-9.624289,"median":-4.665536,"eighty":-2.054897,"marketCap":86245441},{"date":"2025-04-04","current":-0.946604,"twenty":-9.574715,"median":-4.606077,"eighty":-1.965312,"marketCap":61882322},{"date":"2025-04-11","current":-0.685729,"twenty":-9.561032,"median":-4.439593,"eighty":-1.797242,"marketCap":44828138},{"date":"2025-04-17","current":-0.857161,"twenty":-9.511749,"median":-4.37617,"eighty":-1.744126,"marketCap":56035173},{"date":"2025-04-25","current":-0.913063,"twenty":-9.383313,"median":-4.344458,"eighty":-1.606181,"marketCap":59689641},{"date":"2025-05-02","current":-0.883248,"twenty":-9.365642,"median":-4.233469,"eighty":-1.560992,"marketCap":57740592},{"date":"2025-05-09","current":-0.740531,"twenty":-9.335033,"median":-4.213649,"eighty":-1.495984,"marketCap":53111599},{"date":"2025-05-16","current":-0.723546,"twenty":-9.26085,"median":-4.193829,"eighty":-1.480232,"marketCap":51893443},{"date":"2025-05-23","current":-0.672592,"twenty":-9.079462,"median":-4.170046,"eighty":-1.376675,"marketCap":48238975},{"date":"2025-05-30","current":-0.696371,"twenty":-9.046867,"median":-4.104641,"eighty":-1.177664,"marketCap":49944393},{"date":"2025-06-06","current":-0.665798,"twenty":-9.028935,"median":-3.995633,"eighty":-0.946604,"marketCap":47751713},{"date":"2025-06-13","current":-0.696371,"twenty":-8.975602,"median":-3.957976,"eighty":-0.913063,"marketCap":49944393},{"date":"2025-06-20","current":-0.570684,"twenty":-8.968058,"median":-3.829149,"eighty":-0.909336,"marketCap":40930039},{"date":"2025-06-27","current":-0.533318,"twenty":-8.961769,"median":-2.822312,"eighty":-0.881757,"marketCap":38250096},{"date":"2025-07-03","current":-0.546906,"twenty":-8.947831,"median":-2.762854,"eighty":-0.830328,"marketCap":39224621},{"date":"2025-07-11","current":-0.60805,"twenty":-8.911787,"median":-2.592405,"eighty":-0.73948,"marketCap":43609983},{"date":"2025-07-18","current":-0.879805,"twenty":-8.888983,"median":-2.477451,"eighty":-0.736237,"marketCap":63100478},{"date":"2025-07-25","current":-1.168544,"twenty":-8.885996,"median":-2.34466,"eighty":-0.73948,"marketCap":83809129},{"date":"2025-08-01","current":-1.019079,"twenty":-8.836712,"median":-2.219796,"eighty":-0.740531,"marketCap":73089357},{"date":"2025-08-08","current":-0.856075,"twenty":-8.776974,"median":-2.136554,"eighty":-0.74119,"marketCap":64318634},{"date":"2025-08-15","current":-0.877783,"twenty":-8.664966,"median":-2.104843,"eighty":-0.766227,"marketCap":65949557},{"date":"2025-08-22","current":-0.90054,"twenty":-8.539516,"median":-2.017636,"eighty":-0.794855,"marketCap":67659360},{"date":"2025-08-29","current":-1.027331,"twenty":-8.461857,"median":-1.938358,"eighty":-0.806285,"marketCap":77185407},{"date":"2025-09-05","current":-1.011075,"twenty":-8.405106,"median":-1.906646,"eighty":-0.809828,"marketCap":75964119},{"date":"2025-09-12","current":-0.864778,"twenty":-8.31765,"median":-1.769891,"eighty":-0.816568,"marketCap":64972526},{"date":"2025-09-19","current":-0.773749,"twenty":-8.226879,"median":-1.740162,"eighty":-0.790778,"marketCap":58133313},{"date":"2025-09-26","current":-0.978565,"twenty":-8.17661,"median":-1.635118,"eighty":-0.805192,"marketCap":73521543},{"date":"2025-10-03","current":-0.959059,"twenty":-8.149728,"median":-1.601424,"eighty":-0.809828,"marketCap":72055997},{"date":"2025-10-10","current":-0.975314,"twenty":-8.101082,"median":-1.571695,"eighty":-0.816568,"marketCap":73277286},{"date":"2025-10-17","current":-0.90054,"twenty":-8.061078,"median":-1.530074,"eighty":-0.825779,"marketCap":67659360},{"date":"2025-10-24","current":-1.573506,"twenty":-8.013824,"median":-1.539983,"eighty":-0.830317,"marketCap":118220688},{"date":"2025-10-31","current":-1.280912,"twenty":-7.969021,"median":-1.537745,"eighty":-0.833281,"marketCap":96237502},{"date":"2025-11-07","current":-1.11836,"twenty":-7.90156,"median":-1.498363,"eighty":-0.837688,"marketCap":84024621},{"date":"2025-11-14","current":-1.102105,"twenty":-7.858868,"median":-1.490435,"eighty":-0.847643,"marketCap":82803333},{"date":"2025-11-21","current":-0.982565,"twenty":-7.819676,"median":-1.476561,"eighty":-0.856509,"marketCap":77807345},{"date":"2025-11-28","current":-1.16544,"twenty":-7.765913,"median":-1.457948,"eighty":-0.858684,"marketCap":92288839},{"date":"2025-12-05","current":-1.170089,"twenty":-7.585206,"median":-1.427209,"eighty":-0.865066,"marketCap":92657012},{"date":"2025-12-12","current":-0.973266,"twenty":-7.550856,"median":-1.356118,"eighty":-0.866579,"marketCap":77070998},{"date":"2025-12-19","current":-1.441302,"twenty":-7.413459,"median":-1.35655,"eighty":-0.869582,"marketCap":114133803},{"date":"2025-12-26","current":-1.332817,"twenty":-7.317879,"median":-1.35655,"eighty":-0.875795,"marketCap":105543087},{"date":"2026-01-02","current":-1.329717,"twenty":-5.60788,"median":-1.355686,"eighty":-0.876285,"marketCap":105297638},{"date":"2026-01-09","current":-1.419605,"twenty":-5.08879,"median":-1.356118,"eighty":-0.877508,"marketCap":112415660},{"date":"2026-01-16","current":-1.38241,"twenty":-5.065892,"median":-1.373111,"eighty":-0.877783,"marketCap":109470271},{"date":"2026-01-23","current":-1.534289,"twenty":-5.058757,"median":-1.38241,"eighty":-0.877783,"marketCap":121497274},{"date":"2026-01-30","current":-1.286323,"twenty":-5.046865,"median":-1.38396,"eighty":-0.878996,"marketCap":101861351},{"date":"2026-02-06","current":-1.199535,"twenty":-5.015947,"median":-1.373111,"eighty":-0.880542,"marketCap":94988778},{"date":"2026-02-13","current":-1.23673,"twenty":-4.922398,"median":-1.361731,"eighty":-0.882362,"marketCap":97934166},{"date":"2026-02-20","current":-1.404107,"twenty":-4.858976,"median":-1.356118,"eighty":-0.88623,"marketCap":111188415},{"date":"2026-02-27","current":-1.689268,"twenty":-4.776526,"median":-1.370012,"eighty":-0.890736,"marketCap":133769726},{"date":"2026-03-06","current":-1.779155,"twenty":-4.679806,"median":-1.38241,"eighty":-0.892087,"marketCap":140887748},{"date":"2026-03-13","current":-1.989358,"twenty":-4.672671,"median":-1.404107,"eighty":-0.894194,"marketCap":166837536},{"date":"2026-03-20","current":-1.626853,"twenty":-4.654437,"median":-1.418531,"eighty":-0.895573,"marketCap":136436029},{"date":"2026-03-27","current":-1.520754,"twenty":-4.628275,"median":-1.425804,"eighty":-0.898589,"marketCap":127538027},{"date":"2026-04-02","current":-1.989358,"twenty":-4.610834,"median":-1.432003,"eighty":-0.90054,"marketCap":166837536},{"date":"2026-04-10","current":-2.004094,"twenty":-4.574366,"median":-1.4506,"eighty":-0.90119,"marketCap":168073369},{"date":"2026-04-17","current":-3.569056,"twenty":-4.471304,"median":-1.457173,"eighty":-0.904441,"marketCap":299318897},{"date":"2026-04-24","current":-3.330333,"twenty":-4.432458,"median":-1.470747,"eighty":-0.907501,"marketCap":279298393},{"date":"2026-05-01","current":-3.01793,"twenty":-4.398368,"median":-1.476546,"eighty":-0.909336,"marketCap":253098721},{"date":"2026-05-08","current":-3.689891,"twenty":-4.369828,"median":-1.481596,"eighty":-0.910081,"marketCap":309452733},{"date":"2026-05-15","current":-3.031745,"twenty":-4.344458,"median":-1.487795,"eighty":-0.913063,"marketCap":263974056},{"date":"2026-05-22","current":-4.458708,"twenty":-4.432458,"median":-1.494399,"eighty":-0.913063,"marketCap":388219702},{"date":"2026-05-29","current":-4.246654,"twenty":-4.403917,"median":-1.50281,"eighty":-0.913063,"marketCap":369756186},{"date":"2026-06-05","current":-4.285717,"twenty":-4.403917,"median":-1.512592,"eighty":-0.913063,"marketCap":373157360},{"date":"2026-06-12","current":-4.464288,"twenty":-4.403917,"median":-1.532182,"eighty":-0.913063,"marketCap":388705584},{"date":"2026-06-18","current":-5.546878,"twenty":-4.459824,"median":-1.539565,"eighty":-0.913448,"marketCap":482966688},{"date":"2026-06-26","current":-4.927458,"twenty":-4.618762,"median":-1.553857,"eighty":-0.916145,"marketCap":429033788},{"date":"2026-07-02","current":-5.468753,"twenty":-4.679014,"median":-1.559086,"eighty":-0.919028,"marketCap":476164340},{"date":"2026-07-10","current":-5.251119,"twenty":-4.852633,"median":-1.578076,"eighty":-0.922185,"marketCap":457214943},{"date":"2026-07-17","current":-5.044646,"twenty":-4.98936,"median":-1.593497,"eighty":-0.929149,"marketCap":439237309},{"date":"2026-07-24","current":-5.652905,"twenty":-5.058757,"median":-1.601424,"eighty":-0.93305,"marketCap":492198445},{"date":"2026-07-31","current":-5.820316,"twenty":-5.116075,"median":-1.607696,"eighty":-0.93435,"marketCap":506774905},{"date":"2026-08-07","current":-6.195168,"twenty":-5.189342,"median":-1.626853,"eighty":-0.936301,"marketCap":562651332},{"date":"2026-08-14","current":-6.082936,"twenty":-5.239958,"median":-1.667148,"eighty":-0.936301,"marketCap":552458367},{"date":"2026-08-21","current":-5.996806,"twenty":-5.366075,"median":-1.692595,"eighty":-0.938902,"marketCap":544635947},{"date":"2026-08-28","current":-6.427457,"twenty":-5.453128,"median":-1.724769,"eighty":-0.944323,"marketCap":583748044},{"date":"2026-09-04","current":-5.988732,"twenty":-5.513396,"median":-1.759981,"eighty":-0.947685,"marketCap":543902596},{"date":"2026-09-11","current":-5.609221,"twenty":-5.589289,"median":-1.769857,"eighty":-0.949306,"marketCap":509435060},{"date":"2026-09-18","current":-4.543361,"twenty":-5.573664,"median":-1.779478,"eighty":-0.949759,"marketCap":412632621},{"date":"2026-09-25","current":-4.031964,"twenty":-5.544646,"median":-1.803952,"eighty":-0.951767,"marketCap":366187006},{"date":"2026-09-30","current":-3.78434,"twenty":-5.53795,"median":-1.821368,"eighty":-0.952359,"marketCap":343697550}],"updateTime":1790928200737},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ARTV\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2672716093","title":"Artiva Biotherapeutics Price Target Maintained with a $40.00/Share by Cantor Fitzgerald","url":"https://stock-news.laohu8.com/highlight/detail?id=2672716093","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672716093?lang=en_us&edition=fundamental","pubTime":"2026-10-02 18:56","pubTimestamp":1790938560,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ARTV/analyst-ratings","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARTV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672112766","title":"Analysts Offer Insights on Healthcare Companies: Boston Scientific (BSX) and Artiva Biotherapeutics, Inc. (ARTV)","url":"https://stock-news.laohu8.com/highlight/detail?id=2672112766","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672112766?lang=en_us&edition=fundamental","pubTime":"2026-10-02 00:40","pubTimestamp":1790872814,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Boston Scientific (BSX) and Artiva Biotherapeutics, ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-boston-scientific-bsx-and-artiva-biotherapeutics-inc-artv-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-boston-scientific-bsx-and-artiva-biotherapeutics-inc-artv-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1366192091.USD","LU0823417653.USD","LU2265009873.SGD","LU0138981039.USD","LU1291159041.SGD","LU1989764748.USD","HCSG","LU0528227936.USD","LU0048584097.USD","LU0345769631.USD","LU0267386448.USD","LU1804176565.USD","IE00B4R5TH58.HKD","LU2506951958.HKD","IE00BJT1NW94.SGD","LU0432979614.USD","BSX","LU0225283273.USD","LU0353189680.USD","LU2244417387.USD","BK4139","LABU","LU2506952170.USD","LU1061106388.HKD","LU1720051017.SGD","ARTV","XLV","LU1023059063.AUD","SGXZ57979304.SGD","LU2324357040.USD","LU0238689110.USD","IE00BFTCPJ56.SGD","LU1720051108.HKD","LU0251132253.USD","LU0823417737.USD","LU0345769128.USD","SG9999001176.USD","LU0077335932.USD","LU1057294990.SGD","IE0002141913.USD","IE0009355771.USD","BK4137","LU2491049909.HKD","XBI","LU2362541513.USD","BK4585","LU0122379950.USD","BK4504","LU0882574055.USD","LU2491050071.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672276351","title":"Artiva Biosciences: Buy Rating Reiterated on Strong AlloNK Sjögren’s Data and Favorable Safety, Price Target Maintained at $35","url":"https://stock-news.laohu8.com/highlight/detail?id=2672276351","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672276351?lang=en_us&edition=fundamental","pubTime":"2026-10-01 22:55","pubTimestamp":1790866527,"startTime":"0","endTime":"0","summary":"In a report released today, Emily Bodnar from H.C. Wainwright maintained a Buy rating on Artiva Biotherapeutics, Inc., with a price target of $35.0...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/artiva-biosciences-buy-rating-reiterated-on-strong-allonk-sjogrens-data-and-favorable-safety-price-target-maintained-at-35-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/artiva-biosciences-buy-rating-reiterated-on-strong-allonk-sjogrens-data-and-favorable-safety-price-target-maintained-at-35-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","ARTV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672775173","title":"Artiva Highlights Phase 2a AlloNK Plus Rituximab Data in Sjögren Disease Showing Six-Month Symptom Improvement","url":"https://stock-news.laohu8.com/highlight/detail?id=2672775173","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672775173?lang=en_us&edition=fundamental","pubTime":"2026-10-01 19:30","pubTimestamp":1790854219,"startTime":"0","endTime":"0","summary":"Artiva highlights Phase 2a AlloNK plus rituximab data in Sjgren disease showing six-month symptom improvementArtiva Biotherapeutics highlighted updated Phase 2a data for AlloNK (AB-101) with rituximab","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nNDLc8tvg2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKPKM429.USD","IE00BQXX3F31.USD","IE00BN0W2T93.GBP","BCDF","SG9999014005.SGD","BK4588","IE00BN0W2V16.EUR","IE00BN0W2W23.USD","SG9999014039.USD","LU2210149790.SGD","LU2095319765.USD","BK4139","IE00B64PRP62.GBP","ARTV","IE00BQXX3D17.EUR","LU0314104364.USD","IE00B3QW5Z07.USD","LU2210150020.SGD","BK4112","NDAQ","SG9999014021.USD","IE00BQXX3C00.GBP","IE00BGHQF748.EUR","BK4585","SG9999014013.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669488910","title":"Artiva Biotherapeutics to Present Updated AB-101 AlloNK Plus Rituximab Sjögren Disease Data at ISSjD 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2669488910","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669488910?lang=en_us&edition=fundamental","pubTime":"2026-09-23 19:30","pubTimestamp":1790163025,"startTime":"0","endTime":"0","summary":"Artiva Biotherapeutics to present updated AB-101 AlloNK plus rituximab Sjgren disease data at ISSjD 2026Artiva Biotherapeutics flagged updated clinical data for AB-101 with rituximab in Sjgren disease","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260923:nNDL7FhQhl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BCDF","IE00BN0W2V16.EUR","IE00BQXX3D17.EUR","IE00BN0W2T93.GBP","LU0314104364.USD","SG9999014005.SGD","BK4588","SG9999014021.USD","IE00BGHQF748.EUR","SG9999014039.USD","IE00BKPKM429.USD","ARTV","BK4585","LU2095319765.USD","BK4112","BK4139","IE00B64PRP62.GBP","IE00BN0W2W23.USD","SG9999014013.SGD","IE00BQXX3C00.GBP","IE00B3QW5Z07.USD","NDAQ","IE00BQXX3F31.USD","LU2210149790.SGD","LU2210150020.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669488960","title":"Artiva Biotherapeutics Announces Oral Presentation of Allonk® Clinical Data at the 17TH International Symposium on SjÖGren’s Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2669488960","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669488960?lang=en_us&edition=fundamental","pubTime":"2026-09-23 19:30","pubTimestamp":1790163000,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260923:nTUA83HQPL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ARTV","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669167039","title":"H.C. Wainwright Sticks to Their Buy Rating for Artiva Biotherapeutics, Inc. (ARTV)","url":"https://stock-news.laohu8.com/highlight/detail?id=2669167039","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669167039?lang=en_us&edition=fundamental","pubTime":"2026-09-22 01:55","pubTimestamp":1790013349,"startTime":"0","endTime":"0","summary":"In a report released today, Emily Bodnar from H.C. Wainwright maintained a Buy rating on Artiva Biotherapeutics, Inc., with a price target of $35.0...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/h-c-wainwright-sticks-to-their-buy-rating-for-artiva-biotherapeutics-inc-artv-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/h-c-wainwright-sticks-to-their-buy-rating-for-artiva-biotherapeutics-inc-artv-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ARTV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668117964","title":"Artiva Biotherapeutics Joins Stifel Virtual Immunology and Inflammation Forum Fireside Chat","url":"https://stock-news.laohu8.com/highlight/detail?id=2668117964","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668117964?lang=en_us&edition=fundamental","pubTime":"2026-09-17 20:02","pubTimestamp":1789646523,"startTime":"0","endTime":"0","summary":"Artiva Biotherapeutics joins Stifel virtual Immunology and Inflammation Forum fireside chatArtiva Biotherapeutics will join a fireside chat at the Stifel 2026 Virtual Immunology and Inflammation Forum","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260917:nNDL61XpxV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2095319765.USD","BK4139","IE00BN0W2W23.USD","SG9999014013.SGD","IE00BQXX3D17.EUR","IE00BQXX3F31.USD","IE00BN0W2T93.GBP","NDAQ","IE00BN0W2V16.EUR","IE00BKPKM429.USD","BCDF","IE00BQXX3C00.GBP","LU2210150020.SGD","SF","BK4588","LU2210149790.SGD","BK4127","ARTV","LU0314104364.USD","BK4112","IE00B64PRP62.GBP","SG9999014039.USD","IE00BGHQF748.EUR","SG9999014021.USD","BK4585","SG9999014005.SGD","IE00B3QW5Z07.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666574786","title":"Artiva Biotherapeutics Expands Equity Plan, Elects Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2666574786","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666574786?lang=en_us&edition=fundamental","pubTime":"2026-09-12 04:50","pubTimestamp":1789159826,"startTime":"0","endTime":"0","summary":"Artiva Biotherapeutics, Inc. ( ($ARTV) ) has issued an update. On September 8, 2026, Artiva Biotherapeutics held its 2026 annual meeting of stockho...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/artiva-biotherapeutics-expands-equity-plan-elects-directors?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/artiva-biotherapeutics-expands-equity-plan-elects-directors?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","EQR","BK4215","BK4585","BK4588","ARTV","REZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666571072","title":"Artiva Biotherapeutics Shareholders Vote to Expand 2024 Equity Incentive Plan Share Pool by 5,097,095 Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2666571072","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666571072?lang=en_us&edition=fundamental","pubTime":"2026-09-12 04:22","pubTimestamp":1789158157,"startTime":"0","endTime":"0","summary":"Artiva Biotherapeutics shareholders vote to expand 2024 equity incentive plan share pool by 5,097,095 sharesArtiva Biotherapeutics held its annual stockholder meeting on Sept. 8, 2026.Stockholders bac","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260911:nNDL4cbsph:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARTV","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666753717","title":"Artiva Biotherapeutics CEO Fred Aslan Disposes of 23,429 Common Shares Worth $255,725","url":"https://stock-news.laohu8.com/highlight/detail?id=2666753717","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666753717?lang=en_us&edition=fundamental","pubTime":"2026-09-10 04:03","pubTimestamp":1788984210,"startTime":"0","endTime":"0","summary":"Artiva Biotherapeutics CEO Fred Aslan disposes of 23,429 common shares worth $255,725Artiva Biotherapeutics CEO Fred Aslan sold 23,429 shares of common stock on Sept. 8, 2026.Weighted average sale pri","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nNDL6YDH3F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Artiva Biotherapeutics CEO Fred Aslan Disposes of 23,429 Common Shares Worth $255,725","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARTV","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665327936","title":"Artiva Biotherapeutics Launches Phase 3 Trial of AlloNK Plus Rituximab in Refractory Rheumatoid Arthritis","url":"https://stock-news.laohu8.com/highlight/detail?id=2665327936","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665327936?lang=en_us&edition=fundamental","pubTime":"2026-09-08 19:32","pubTimestamp":1788867146,"startTime":"0","endTime":"0","summary":"Artiva Biotherapeutics launches Phase 3 trial of AlloNK plus rituximab in refractory rheumatoid arthritisArtiva outlined second-half 2026 data disclosures for AlloNK with rituximab in its Phase 2a aut","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDL1brkJ9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BCDF","LU2095319765.USD","IE00B3QW5Z07.USD","IE00BKPKM429.USD","SG9999014021.USD","LU2210149790.SGD","SG9999014013.SGD","LU0314104364.USD","BK4112","IE00BN0W2V16.EUR","NDAQ","BK4588","SG9999014005.SGD","IE00BQXX3D17.EUR","IE00BGHQF748.EUR","IE00BN0W2T93.GBP","LU2210150020.SGD","BK4585","IE00BN0W2W23.USD","IE00BQXX3C00.GBP","BK4139","ARTV","IE00BQXX3F31.USD","IE00B64PRP62.GBP","SG9999014039.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665327687","title":"Artiva Biotherapeutics Provides Update on Planned Allonk® Data Disclosures and Development Milestones for the Remainder of 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2665327687","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665327687?lang=en_us&edition=fundamental","pubTime":"2026-09-08 19:30","pubTimestamp":1788867001,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nTUA4TYRM1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ARTV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665327572","title":"Artiva Biotherapeutics - to Disclose Updated Phase 2a Ra Data from at Least 20 Patients in H2 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2665327572","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665327572?lang=en_us&edition=fundamental","pubTime":"2026-09-08 19:30","pubTimestamp":1788867001,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nTUA4TYRM1:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ARTV","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665275073","title":"Artiva Biotherapeutics - Expects Phase 3 Ra Trial Topline Results by End of 2028","url":"https://stock-news.laohu8.com/highlight/detail?id=2665275073","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665275073?lang=en_us&edition=fundamental","pubTime":"2026-09-08 19:30","pubTimestamp":1788867001,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nTUA4TYRM1:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ARTV","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665378124","title":"Artiva Biotherapeutics Provides Update on Planned AlloNK® Data Disclosures and Development Milestones for the Remainder of 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2665378124","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665378124?lang=en_us&edition=fundamental","pubTime":"2026-09-08 19:30","pubTimestamp":1788867000,"startTime":"0","endTime":"0","summary":"Updated clinical data expected in the second half of 2026 from at least 20 patients with refractory rheumatoid arthritis (RA) treated with AlloNK and rituximab in the ongoing company-sponsored Phase 2","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/08/3357530/0/en/artiva-biotherapeutics-provides-update-on-planned-allonk-data-disclosures-and-development-milestones-for-the-remainder-of-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RA","BK4139","ARTV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665357770","title":"Top Artiva Biotherapeutics Executives Quietly Unload a Wave of Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2665357770","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665357770?lang=en_us&edition=fundamental","pubTime":"2026-09-05 10:06","pubTimestamp":1788574013,"startTime":"0","endTime":"0","summary":"New insider activity at Artiva Biotherapeutics, Inc. ( ($ARTV) ) has taken place on September 4, 2026. Artiva Biotherapeutics, Inc. has seen signif...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/top-artiva-biotherapeutics-executives-quietly-unload-a-wave-of-shares-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/top-artiva-biotherapeutics-executives-quietly-unload-a-wave-of-shares-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ARTV","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664811265","title":"Artiva Biotherapeutics to Participate in Upcoming Investor Conferences in September","url":"https://stock-news.laohu8.com/highlight/detail?id=2664811265","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664811265?lang=en_us&edition=fundamental","pubTime":"2026-09-02 20:30","pubTimestamp":1788352200,"startTime":"0","endTime":"0","summary":"SAN DIEGO, Sept.  02, 2026 (GLOBE NEWSWIRE) -- Artiva Biotherapeutics, Inc. (Nasdaq: ARTV) (Artiva), a clinical-stage biotechnology company whose mission is to develop effective, safe and accessible c","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/02/3355154/0/en/artiva-biotherapeutics-to-participate-in-upcoming-investor-conferences-in-september.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RA","BK4139","ARTV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664869118","title":"Artiva Biotherapeutics CMO Subhashis Banerjee Disposes of 8,222 Shares for $98,730.32","url":"https://stock-news.laohu8.com/highlight/detail?id=2664869118","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664869118?lang=en_us&edition=fundamental","pubTime":"2026-09-01 07:07","pubTimestamp":1788217640,"startTime":"0","endTime":"0","summary":"Artiva Biotherapeutics CMO Subhashis Banerjee disposes of 8,222 shares for $98,730.32Artiva Biotherapeutics Chief Medical Officer Subhashis Banerjee sold 8,222 common shares on Aug. 27 at USD 12.01.He","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nNDLb5ByDm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Artiva Biotherapeutics CMO Subhashis Banerjee Disposes of 8,222 Shares for $98,730.32","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ARTV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660749764","title":"Artiva Biotherapeutics CMO Subhashis Banerjee Disposes of 429 Common Shares Worth $5,148 Under 10b5-1 Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2660749764","media":"Reuters","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660749764?lang=en_us&edition=fundamental","pubTime":"2026-08-20 09:01","pubTimestamp":1787187675,"startTime":"0","endTime":"0","summary":"Artiva Biotherapeutics CMO Subhashis Banerjee disposes of 429 common shares worth $5,148 under 10b5-1 planArtiva Biotherapeutics Chief Medical Officer Subhashis Banerjee sold 429 common shares on Aug.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nNDL2KsMjq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Artiva Biotherapeutics CMO Subhashis Banerjee Disposes of 429 Common Shares Worth $5,148 Under 10b5-1 Plan","news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARTV","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":1,"totalSize":99,"code":"91000000","status":"200"}]}}